Persistence to guideline-based therapy newly prescribed after a hospitalization for heart failure. Data from two large cohorts in the US and Germany.
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Bayer AG, Basel (Switzerland)
7 More presentations in this session
Doctor M. Gamero (Philadelphia, US)
Mr M. Ferrari (Brescia, IT)
Doctor A. Jordan (Mexico City, MX)
Doctor P. Rocha Carvalho (Vila Real, PT)
Associate Professor R. Rascon Sabido (Veracruz, MX)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
